LINC00665 and non-small cell lung carcinoma: In terms of NSCLC, the up-regulated LINC00665 level has been involved in the resistance of NSCLC cells to Gefitinib and Cisplatin [34, 35], and downregulation of LINC00665 attenuates NSCLC cell viability and invasion [17].